(Q30580622)
Statements
Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach (English)
Zhichao Zhang
Ting Song
Xiangqian Li
Zhiyong Wu
Feibo Xie
Chengwu Liu
Jianquan Qin
7 November 2012